These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 26817504
1. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA. Am J Clin Nutr; 2016 Mar; 103(3):851-60. PubMed ID: 26817504 [Abstract] [Full Text] [Related]
2. A comparison of plasma and prostate lycopene in response to typical servings of tomato soup, sauce or juice in men before prostatectomy. Grainger EM, Hadley CW, Moran NE, Riedl KM, Gong MC, Pohar K, Schwartz SJ, Clinton SK. Br J Nutr; 2015 Aug 28; 114(4):596-607. PubMed ID: 26202168 [Abstract] [Full Text] [Related]
7. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG. Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA. Eur Urol; 2019 Jul 28; 76(1):33-40. PubMed ID: 30301696 [Abstract] [Full Text] [Related]
8. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. Chen J, Song Y, Zhang L. J Nutr Sci Vitaminol (Tokyo); 2013 Jul 28; 59(3):213-23. PubMed ID: 23883692 [Abstract] [Full Text] [Related]
9. Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer. Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, Wilson KM, Markt SC, Pernar CH, Gonzalez-Feliciano AG, Song M, Lis RT, Schmidt DR, Vander Heiden MG, Fiorentino M, Giovannucci EL, Loda M, Mucci LA. Cancer Epidemiol Biomarkers Prev; 2018 Feb 28; 27(2):193-200. PubMed ID: 29167279 [Abstract] [Full Text] [Related]
10. Intake of carotenoids and retinol in relation to risk of prostate cancer. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. J Natl Cancer Inst; 1995 Dec 06; 87(23):1767-76. PubMed ID: 7473833 [Abstract] [Full Text] [Related]
13. The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Pettersson A, Graff RE, Bauer SR, Pitt MJ, Lis RT, Stack EC, Martin NE, Kunz L, Penney KL, Ligon AH, Suppan C, Flavin R, Sesso HD, Rider JR, Sweeney C, Stampfer MJ, Fiorentino M, Kantoff PW, Sanda MG, Giovannucci EL, Ding EL, Loda M, Mucci LA. Cancer Epidemiol Biomarkers Prev; 2012 Sep 06; 21(9):1497-509. PubMed ID: 22736790 [Abstract] [Full Text] [Related]
14. V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application. Park K, Chiu YL, Rubin MA, Demichelis F, Mosquera JM. Hum Pathol; 2013 Oct 06; 44(10):2282-92. PubMed ID: 23856515 [Abstract] [Full Text] [Related]
15. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andrén O, Johnson LA, Tang J, Adami HO, Calza S, Chinnaiyan AM, Rhodes D, Tomlins S, Fall K, Mucci LA, Kantoff PW, Stampfer MJ, Andersson SO, Varenhorst E, Johansson JE, Brown M, Golub TR, Rubin MA. J Natl Cancer Inst; 2008 Jun 04; 100(11):815-25. PubMed ID: 18505969 [Abstract] [Full Text] [Related]
16. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion. Tsourlakis MC, Weigand P, Grupp K, Kluth M, Steurer S, Schlomm T, Graefen M, Huland H, Salomon G, Steuber T, Wilczak W, Sirma H, Simon R, Sauter G, Minner S, Quaas A. Am J Pathol; 2014 Mar 04; 184(3):609-17. PubMed ID: 24378408 [Abstract] [Full Text] [Related]
17. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer. Graff RE, Pettersson A, Lis RT, DuPre N, Jordahl KM, Nuttall E, Rider JR, Fiorentino M, Sesso HD, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Nguyen PL, Sweeney CJ, Mucci LA, Transdisciplinary Prostate Cancer Partnership ToPCaP. Prostate; 2015 Jun 15; 75(9):897-906. PubMed ID: 25728532 [Abstract] [Full Text] [Related]
18. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Giovannucci E. Exp Biol Med (Maywood); 2002 Nov 15; 227(10):852-9. PubMed ID: 12424325 [Abstract] [Full Text] [Related]
19. Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Wang Y, Jacobs EJ, Newton CC, McCullough ML. Int J Cancer; 2016 Jun 15; 138(12):2846-55. PubMed ID: 26830232 [Abstract] [Full Text] [Related]
20. Marked heterogeneity of ERG expression in large primary prostate cancers. Minner S, Gärtner M, Freudenthaler F, Bauer M, Kluth M, Salomon G, Heinzer H, Graefen M, Bokemeyer C, Simon R, Sauter G, Schlomm T, Wilczak W. Mod Pathol; 2013 Jan 15; 26(1):106-16. PubMed ID: 22899295 [Abstract] [Full Text] [Related] Page: [Next] [New Search]